AstraZeneca bets on the future of the ‘secretome,’ joining a $100M research effort

Damian Garde

, on the hunt for new drug targets, is teaming up with a Swedish outfit to explore the potential of an emerging class of proteins, a $ 100 million initiative.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS